Zenosense, Inc.: MIDS Medical JV to Receive Funding of Up to $1.2 Million

Sep 05, 2018 OTC Disclosure & News Service VALENCIA, SPAIN, Sept. 05, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Zenosense, Inc. (OTCQB: ZENO, “Zenosense”, the “Company”), a healthcare technology company focused on the development and commercialization of the MIDS Cardiac™ hand-held technology for the early detection of heart attack at the Point of Care, is…